Cargando…

INCREASING BURDEN OF ANTIMICROBIAL RESISTANCE IN PSEUDOMONAS AERUGINOSA FROM ADULT PATIENTS WITH CYSTIC FIBROSIS (CF) IN NORTHERN IRELAND: THEN AND NOW

Detalles Bibliográficos
Autores principales:	Gramegna, Andrea, Moore, John E., McCaughan, John, Millar, B. Cherie, Ewing, Judith, Elborn, J. Stuart, Blasi, Francesco, Downey, Damian G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Ulster Medical Society 2018
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974647/ https://www.ncbi.nlm.nih.gov/pubmed/29867273

Ejemplares similares

TACKLING ANTIMICROBIAL RESISTANCE (AMR) - IN VITRO EFFECT OF SODIUM CHLORIDE ON ANTIBIOTIC SUSCEPTIBILITY IN CLINICAL PSEUDOMONAS AERUGINOSA ISOLATED FROM PATIENTS WITH CYSTIC FIBROSIS (CF)
por: Gramegna, Andrea, et al.
Publicado: (2020)

The Microbiology of Non-aeruginosa Pseudomonas Isolated From Adults With Cystic Fibrosis: Criteria to Help Determine the Clinical Significance of Non-aeruginosa Pseudomonas in CF Lung Pathology
por: Moore, John E., et al.
Publicado: (2022)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

Early detection of Pseudomonas aeruginosa – comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF)
por: Xu, Jiru, et al.
Publicado: (2004)

Who’s at The Door? – Surface Contamination of Door Frames in a Single-Bedded In-Patient Adult Cystic Fibrosis (CF) Unit
por: Furukawa, Maika, et al.
Publicado: (2020)

The virtual CF clinic: Implications for sputum microbiology
por: Moore, John E., et al.
Publicado: (2021)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His
por: Shteinberg, Michal, et al.
Publicado: (2017)

Public Health Bacteriology of Commercially Composted Domestic Food and Garden Waste by the 11 Councils in Northern Ireland – Persistence Of Clostridium perfringens and Implications for Local Food Safety
por: Furukawa, Maika, et al.
Publicado: (2018)

Molecular epidemiology of clinical isolates of Pseudomonas aeruginosa isolated from horses in Ireland
por: Tazumi, A, et al.
Publicado: (2009)

Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
por: Keown, Karen, et al.
Publicado: (2020)

MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis
por: Vallières, Emilie, et al.
Publicado: (2016)

Thinking inside the box: nebulizer care, safe storage, and risk of infection in cystic fibrosis
por: Alexander, Lauren, et al.
Publicado: (2020)

Nebuliser hygiene in cystic fibrosis: evidence-based recommendations
por: Bell, Jane, et al.
Publicado: (2020)

Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection
por: Mantero, Marco, et al.
Publicado: (2017)

Discovery of inhibition of Burkholderia cenocepacia, Pseudomonas aeruginosa and Stenotrophomonas maltophilia by the Brown Rot Basidiomycete Fungus, Postia placenta
por: McIlroy, Rachael, et al.
Publicado: (2021)

Does Pseudomonas aeruginosa Colonization Affect Exercise Capacity in CF?
por: Kampouras, Asterios, et al.
Publicado: (2019)

Emergence of community-associated MRSA (CA-MRSA) in Northern Ireland
por: Loughrey, Anne, et al.
Publicado: (2007)

THE MICROBIOLOGY OF THE CAMÁN
por: Moore, John E., et al.
Publicado: (2020)

Perinatal mortality in Northern Ireland: where are we now?
por: Kee, F., et al.
Publicado: (1989)

Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry
por: Vongthilath, Réchana, et al.
Publicado: (2019)

1107. Three Year Longitudinal Assessment of Pseudomonas aeruginosa (Pa) Antibiotic Susceptibility in Children with Cystic Fibrosis (CF) in the Era of Modulator Therapy
por: Bradley, John, et al.
Publicado: (2023)

Evaluation of tests to predict metallo-β-lactamase in cystic fibrosis (CF) and non-(CF) Pseudomonas
por: Perez, Leandro Reus Rodrigues, et al.
Publicado: (2014)

Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
por: Hewer, Simon C Langton, et al.
Publicado: (2020)

Pseudomonas aeruginosa Cystic Fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro
por: Deligianni, Elena, et al.
Publicado: (2010)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

ANTIMICROBIAL RESISTANCE IN CAMPYLOBACTER ISOLATES FROM SPORADIC CASES OF ACUTE HUMAN GASTROENTERITIS IN NORTHERN IRELAND
por: Moore, John E, et al.
Publicado: (2009)

Fermentation products in the cystic fibrosis airways induce aggregation and dormancy-associated expression profiles in a CF clinical isolate of Pseudomonas aeruginosa
por: Phan, Joann, et al.
Publicado: (2018)

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
por: Clancy, J P, et al.
Publicado: (2013)

COMPARISON OF PUBLIC PERCEPTIONS ASSOCIATED WITH HEALTHCARE-ASSOCIATED INFECTIONS (HCAIS) IN NORTHERN IRELAND FOLLOWING THE 2007/2008 OUTBREAK OF CLOSTRIDIUM DIFFICILE IN THE NORTHERN TRUST
por: Moore, John E., et al.
Publicado: (2010)

1602. Comparative Activity of Ceftolozane-Tazobactam (C/T) and Ceftazidime-Avibactam (CZA) against Pseudomonas aeruginosa (PSA) from Patients with Cystic Fibrosis (CF)
por: Lasko, Maxwell J, et al.
Publicado: (2020)

Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
por: Cramer, Nina, et al.
Publicado: (2014)

Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice
por: Sandri, Angela, et al.
Publicado: (2018)

Improving health literacy of antibiotic use in people with cystic fibrosis (CF)—comparison of the readability of patient information leaflets (PILs) from the EU, USA and UK of 23 CF-related antibiotics used in the treatment of CF respiratory infections
por: Tang, Ka Wah Kelly, et al.
Publicado: (2023)

Public Understanding of Coercive Control in Northern Ireland
por: Lagdon, Susan, et al.
Publicado: (2022)

13. Evaluation of Etest for Antibiotic Susceptibility and Minimum Inhibitory Concentration (MIC) Agreement Against pseudomonas Aeruginosa (psa) from Patients with Cystic Fibrosis (CF)
por: Lasko, Maxwell J, et al.
Publicado: (2020)

ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
por: Lausen, M., et al.
Publicado: (2022)

Nutrient Availability as a Mechanism for Selection of Antibiotic Tolerant Pseudomonas aeruginosa within the CF Airway
por: Hoffman, Lucas R., et al.
Publicado: (2010)

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
por: Sordé, Roger, et al.
Publicado: (2011)

Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
por: Bhagirath, Anjali Y., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a215id82q1j10a8hv6lcni28jl